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Background: This study was designed to investigate the correlations of knee osteoarthritis (OA) with metabolic
syndrome (MetS) and MetS parameters in Korean subjects.
Methods: This study included data from 270 subjects with knee OA and 1964 control subjects with a mean age of
54.56 (SD 11.53) years taken from the Korean National Health and Nutritional Examination Survey (KNHANES) 2008.
Multivariate logistic regression analysis was conducted to examine possible associations for knee OA with MetS and
MetS parameters.
Results: MetS was shown to be associated with an increased risk of knee OA in female subjects in unadjusted
analysis (OR 1.798, 95% CI 1.392, 2.322), but this significance disappeared when adjusted for confounding factors
(OR 1.117, 95% CI 0.805, 1.550). No significant association between MetS and knee OA was found in male subjects.
Among parameters of MetS, only high waist circumference (WC) in female subjects was significantly associated with
an increased prevalence of knee OA, even after adjusting for confounding factors, while no other significant
associations were found in both male and female subjects.
Conclusion: We found that WC was associated with knee OA in female subjects, but neither MetS nor any
parameters thereof were shown to be associated with knee OA in the Korean subjects of this study. Although we
found no relationship between a pre-inflammatory state of MetS and knee OA, we believe further investigation of
this relationship in various aspects is warranted, as MetS may also be a risk factor for complications in knee OA
related procedures.
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Osteoarthritis (OA) of the knee is a widely prevalent dis-
ease characterized by pain and limitations in daily activ-
ities caused by gradual deterioration and inflammation
of the articular cartilages [1]. Of particular concern, the
worldwide health and economic burden of knee OA will
likely increase in the future, as longer life expectancy
will lead to a growing elderly population [2]. The patho-
physiologic mechanisms of OA are under debate, but* Correspondence: kkpark@yuhs.ac
Department of Orthopaedic Surgery, Yonsei University College of Medicine,
Seoul, Republic of Korea
© 2013 Han et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orthere is general agreement that biomechanics and in-
creased dynamic loading of the joint are involved [3].
However, it is suggested that other factors such as gen-
etic, metabolic, and neuroendocrine factors may also con-
tribute to increased incidences of knee OA [4].
Metabolic syndrome (MetS) comprises a number of
conditions, including obesity, atherogenic dyslipidemia,
impaired fasting glucose and hypertension (HTN), the
prevalence of which has rapidly increased [5]. Nonethe-
less, a significantly increased risk of cardiovascular disease
[6] and mortality [7] are reported among patients with
metabolic syndrome. In musculoskeletal fields, MetS has
gradually garnered greater attention due to an association. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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thrombosis after procedures related to knee OA, such as
total knee arthroplasty (TKA) [9]. Obesity, a key factor in
MetS, is well known to be associated with knee OA in
terms of mechanical load, [10,11] and it is also thought
to be related to excessive proinflammatory cytokine pro-
duction which could play a pathophysiologic role in OA
[12-16]. Furthermore, it has been also reported that
atherogenic effects related to HTN could change the mi-
crovasculature of subchondral bone [17] and could have
an effect on the development of knee OA. Nevertheless,
studies concerning the synchronous effects of MetS and
the parameters thereof on knee OA are limited [3,8].
Therefore, in this study, we attempted to determine
the relationships between knee OA, MetS and MetS pa-
rameters through a population-based study. This study
had two purposes: 1) to examine the relationship between
MetS and knee OA and 2) to determine the associations
between MetS parameters and knee OA.
Methods
Data source and subjects
Data were obtained from the Korean National Health
and Nutrition Examination Survey (KNHANES) 2008.
KNHANES was conducted by the Ministry of Health and
Welfare [18]. A stratified multistage probability sampling
design was used to generate representative data among
non-institutionalized Korean civilians [18]. A flowchart
for the inclusion of the subjects in this study is presented
in Figure 1. Among 37,878 subjects that participated in
KNHANES, 27,042 subjects who did not respond to the
first question of “Have you ever been diagnosed as having
knee OA by a physician?” were excluded, while 2,635 sub-
jects who responded by saying ‘yes’ and 8,204 subjectsFigure 1 Subjects included in the current study. KNHSNES = Korean N
M = month; RA = rheumatoid arthritis; MetS = metabolic syndrome.who responded by saying ‘no’ were included in the study.
In an attempt to include patients with recently-inflicted
knee OA, of those 2,635 subjects who responded ‘yes’ to
the previous question, 2,001 patients who either did not
respond or responded by saying ‘no’ to the question of
“Have you had knee pain for the past month or longer?”
were excluded from this study; the remaining 634 subjects
responded by saying ‘yes’. Among them, 194 subjects
with a history of trauma, rheumatoid arthritis, or a non
skin cancerous lesion and 170 with incomplete data for
variables defining MetS were excluded from this study.
Finally, 270 subjects were recruited as ‘subjects with knee
OA’ and their mean age was 64.5 (SD 10.1) years old with
a range of 40 to 90 years old. Of those 8,204 subjects
who responded ‘no’ to the first question, 4,303 subjects
with an age of less than forty years old were excluded in
order to minimize age bias. Of those remaining 3,901
subjects, in an attempt to exclude those who had not been
diagnosed as having knee OA, but had the possibility of
having knee OA, this study excluded 797 subjects who
replied ‘yes’ or who did not reply to the question of
“Have you had knee pain for the past month or longer?”
The remaining 3104 subjects were categorized as con-
trol subjects. Among them, except for 414 subjects with
a history of trauma, rheumatoid arthritis, or non skin
cancerous lesion and 726 subjects with incomplete data
for variables defining MetS, 1,964 subjects were finally
recruited as the control subjects. The mean age of this
group was 53.2 (SD 11.0) years old with a range of 40 to
91 years old.
Covariates
Data concerning clinical characteristics were collected
by history taking, physical examinations and laboratoryational Health and Nutrition Examination Survey; OA = osteoarthritis;
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medical history, and lifestyle habits. Cigarette smoking
was categorized as never smokers, ex-smokers and current
smokers, and alcohol use was dichotomized as current
users and nonusers. Physical examinations included mea-
surements of blood pressure and measures of body mass.
Blood pressure was measured using a mercury sphygmo-
manometer in a seated position after a 10-minute rest
period. Two measurements were made for all subjects at
5-minute intervals. An average of two measurements
was used for the data analyses. Weight was measured on
a calibrated balance-beam scale and height was mea-
sured in an upright position using a stadiometer. BMI
was calculated by dividing weight (Kg) by height2 (square
meters). Waist circumference (WC) was measured at the
midpoint between the bottom of the rib cage and the top
of the lateral border of the iliac crest with full expiration.
Blood samples were collected from subjects on the morn-
ing after an overnight fasting, and analyzed at a national
central laboratory.
Metabolic syndrome
The presence of MetS was defined using the National
Cholesterol Education Program (NCEP ATPIII) [19]. The
cut-offs established for Korean adults, as proposed by “The
Korean Society for the Study of Obesity”, were adopted for
the criterion of abdominal obesity [20]. The criterion for
high glucose was adopted from the guidelines established
by the American Diabetes Association [21]. Subjects with
three of more of the following parameters were considered
as having MetS: abdominal obesity (WC ≥90 cm in men
and ≥80 cm in women); hypertriglyceridemia ≥150 mg/dl;
low high density lipoprotein cholesterol (HDL – C)
<40 mg/dl in men and <50 mg/dl in women; high blood
pressure ≥130/85 mmHg or use of antihypertensive
medication; or high fasting glucose ≥100 mg/dl or under
treatment for diabetes.
Statistics
Clinical characteristics among the subjects with knee OA
and controls were compared by Student’s t test for con-
tinuous variables and Pearson’s Chi square test or Fisher’s
exact test for categorical variables. Multivariate logistic re-
gression analysis was conducted to evaluate relationships
between knee OA with MetS itself or its parameters. WC
was divided into sex-specific quartiles to examine its rela-
tionship with the prevalence of knee OA. Statistical ana-
lysis was performed with the SPSS for Windows statistical
package (version 20.0, SPSS Inc., Chicago, IL), and all
P-values < .05 were considered significant.
Ethics
KNHANES 2008 was performed by the Ministry for Health,
Welfare and Family Affairs (MIHWAF) of Korea andthe Korea Centers for Disease Control and Prevention
(KCDC) and was approved by the institutional review
board of KCDC (Registration number: 2009-I3).
Results
Clinical characteristics according to the presence or ab-
sence of knee OA are shown in Table 1. The prevalence
of knee OA in this study was 12.1% (n = 270) in total,
4.0% (n = 41) in men and 18.9% (n = 229) in women.
Compared with subjects without knee OA, those with knee
OA had higher mean age, BMI, WC, SBP, and LDL - C,
as well as a higher prevalence of smoking (current and
ex-smoking); meanwhile, they had lower mean weight
and height, as well as a lower prevalence of exercise and
alcohol intake (Table 1). In women, a greater number of
clinical characteristics were significantly different be-
tween subjects with and those without knee OA than in
men (Table 1).
The prevalences of knee OA and MetS, as well as the
prevalence of MetS according to the presence or absence
of knee OA, for individual age groups are shown in
Figures 2 and 3 and Table 2. The prevalence rate of
knee OA for patients in their 40s was 1.9% (0.7%, male;
2.9%, female), while that for patients in their 80s or
older was 35.7% (22.2%, male; 42.1%, female), revealing
an increasing prevalence for knee OA as patients became
older (Figure 2). Except for patients in their 80s, the
prevalence rate was significantly higher in females. In this
study, the overall prevalence rate of MetS in all patients
was 37.5% in males and 38.3% in females, showing a
gradual increasing trend as one became older (Figure 3).
Among those in their 40s, males exhibited a significantly
higher prevalence rate of MetS, but the remaining age
groups showed statistically similar or higher prevalence
rates among females. In each age group, the prevalence
of MetS was compared among patients with or without
knee OA. However, there were no significant differences
among overall patients, male or female (Table 2).
MetS was associated with an increased risk of knee
OA in female subjects prior to adjustment for potential
confounding factors (OR 1.798, 95% CI 1.392, 2.322), but
this significance disappeared when adjusted for age and
sociographic factors of exercise, alcohol intake and smok-
ing (OR 1.117, 95% CI 0.805, 1.550). No significant asso-
ciation between MetS and knee OA was found in male
subjects prior to adjusting (OR 1.117, 95% CI 0.805, 1.550)
or after adjusting for age and sociodemographic factors
(OR 0.946, 95% CI 0.438, 1.852). The relationships of knee
OA with parameters of MetS are shown in Table 3. Among
parameters of MetS, only high waist circumference (WC)
was significantly associated with an increased prevalence
of knee OA in female subjects prior to adjusting (OR
2.004, 95% CI 1.464, 2.743), as well as after adjusting,
for age and confounding factors (OR 1.838, 95% CI
Table 1 Clinical characteristics of subjects by presence or absence of knee OA (n =2234)
All Men Women
No (n = 1964) Yes (n = 270) No (n = 979) Yes (n = 41) No (n = 985) Yes (n = 229)
Age (y) 53.2 ± 11.0‡ 64.5 ± 10.1 53.8 ± 10.8‡ 65.3 ± 10.5 52.6 ± 11.3‡ 64.3 ± 10.0
Weight (kg) 62.0 ± 10.1‡ 58.3 ± 9.5 66.6 ± 9.6§ 63.9 ± 10.8 57.5 ± 8.5 57.3 ± 8.9
Height (cm) 161.2 ± 8.7‡ 153.9 ± 7.6 167.4 ± 6.0* 165.2 ± 5.8 155.0 ± 6.1‡ 151.8 ± 6.0
BMI (kg/m2) 23.8 ± 3.1‡ 24.6 ± 3.3 23.7 ± 2.9 23.4 ± 3.6 23.9 ± 3.2‡ 24.8 ± 3.2
WC (cm) 82.7 ± 8.7‡ 85.0 ± 9.5 85.3 ± 7.9 85.9 ± 9.9 80.1 ± 8.7‡ 84.8 ± 9.4
SBP (mmHg) 126.4 ± 20.2‡ 133.2 ± 20.9 128.7 ± 19.3 132.8 ± 20.5 124.0 ±20.7‡ 133.3 ± 21.0
DBP (mmHg) 79.5 ± 11.5 79.4 ± 12.0 81.7 ± 11.5* 77.0 ± 11.8 77.4 ± 11.2† 79.8 ± 12.1
Fasting glucose (mg/dL) 99.2 ± 18.2 99.9 ± 17.9 100.2 ± 18.6 99.5 ± 17.0 98.3 ± 17.7 100.0 ± 18.1
HDL - C (mg/dL) 45.5 ± 10.3 45.0 ± 10.2 163.4 ± 84.4 153.9 ± 80.5 47.5 ± 10.2† 45.5 ± 9.8
TG (mg/dL) 148.2 ± 79.7 149.7 ± 66.3 43.5 ± 10.0 42.6 ± 12.4 133.2 ± 71. 6† 149.0 ± 63.7
Exercise 594 (30.2)† 58 (21.6) 340 (34.7) 13 (31.7) 254 (25.8)§ 45 (19.7)
Alcohol intake 1305 (66.4)‡ 134 (49.6) 816 (83.4) 35 (85.4) 489 (49.6)§ 99 (43.2)
Smoking
Never 1131 (57.6)‡ 209 (77.4) 210 (21.5)* 5 (12.2) 921 (93.5)§ 204 (89.1)
Current 590 (30.0) 40 (14.8) 535 (54.6) 19 (46.3) 55 (5.6) 21 (9.2)
Ex-smoker 243 (12.4) 21 (7.8) 234 (23.9) 17 (41.5) 9 (0.9) 4 (1.7)
Abbreviations: OA osteoarthritis, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, HDL - C high density
lipoprotein cholesterol; TG triglyceride.
Values are presented with mean ± standard deviations or number (%).
P-values: Student’s t test & Chi-square test or Fisher’ exact test; .050 < §P < .1, *P < .050, †P < .010, ‡P < .001.
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cant. No parameter of MetS was significantly associated
with knee OA in male subjects (Table 3).
In order to investigate the effect of WC on the preva-
lence of knee OA, WC was categorized into quartiles, and
its relationships with knee OA was analyzed by multi-
variate logistic regression analyses (Table 4). The ad-
justed OR for knee OA with WC in the fourth quartileFigure 2 Prevalence of knee OA according to age groups.
*P value < .050 by Chi square test or Fisher’s exact test between
male and female subjects. OA = osteoarthritis.was 2.3 (1.144 – 3.546), when adjusted for age, exercise,
alcohol intake, and smoking in women (Table 4).Discussion
This study investigated 1) relationships between MetS and
knee OA, as well as 2) associations between each param-
eter of MetS and knee OA, via a population-based study.Figure 3 Prevalence of MetS according to age groups. *P value < .050
by Chi square test or Fisher’s exact test between male and female
subjects. MetS = metabolic syndrome.
Table 2 Prevalence of MetS of subjects by presence or absence of knee OA
Age (y) All Men Women
Non - OA OA P Non - OA OA P Non - OA OA P
40–49 244/945 (25.8%) 1/18 (5.6%) .056 139/434 (32.0%) 0/3 (0%) .555 105/511 (20.5%) 1/15 (6.7%) .325
50–59 190/471 (40.3%) 29/72 (40.3%) 1.000 98/253 (38.7%) 5/10 (50.0%) .520 92/218 (42.2%) 24/62 (38.7%) .663
60–69 175/355 (49.3%) 49/92 (53.3%) .559 82/202 (40.6%) 5/14 (35.7%) .786 93/153 (60.8%) 44/78 (56.4%) .572
70–79 78/157 (49.7%) 43/68 (63.2%) .080 34/76 (44.7%) 3/10 (30.0%) .504 44/81 (54.3%) 40/58 (69.0%) .113
≥80 15/36 (41.7%) 13/20 (65.0%) .162 4/14 (28.6%) 2/4 (50.0%) .569 11/22 (50.0%) 11/16 (68.8%) .326
Abbreviations: MetS metabolic syndrome, OA osteoarthritis.
Values are presented with number (%).
P-value: Chi square test or Fisher’s exact test.
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an increased risk of knee OA in female subjects.
The literature consensually agrees that the prevalence
of MetS is increasing to a dangerous proportion [22-27].
The main concerns with the increasing prevalence of
MetS are an increasing risk of diabetes [28] and cardio-
vascular disease [6]. As it affects knee OA, MetS is of
particular concern for the following reasons: 1) obesity,
a major key factor of MetS, has been shown to exert a
direct mechanical effect on knee OA [10,11]; 2) in
addition to the mechanical effect of obesity on knee OA,
MetS as a pre-inflammatory condition might have a det-
rimental effect on the cartilages of the knee [29,30]; and
3) MetS potentially poses an increased risk of embolism
in arthroplasty or other orthopaedic surgeries [9]. How-
ever, studies on the relationship between MetS and OA
are limited [3,8]. Recently, Engström et al. [3] reported
that MetS is associated with an increased incidence of
knee OA when adjusted for age, sex and social factors in
a Western population based study. They reported that
this was largely explained by increased BMI; however,
CRP was not associated with the incidence of knee OA
after adjusting for confounding factors [3]. Gandhi et al.
[8] reported that MetS is a risk factor for OA in Asians.
In our study, MetS was not associated with an increased
risk of knee OA after adjusting for confounding factors.
A possible reason for the discordance between MetS andTable 3 ORs (95% CI) for knee OA according to parameters of
Model 1
Male Fem
OR (95% CI) OR (95
WC (≥ 90/80 cm) 1.229 (0.615, 2.457) 2.004 (1.46
HTN 1.113 (0.586, 2.115) 2.000 (1.47
Hyperglycemia 1.334 (0.703, 2.533) 0.909 (0.67
Hypertriglyceridemia 0.798 (0.416, 1.530) 1.138 (0.82
Low HDL - C 1.202 (0.625, 2.311) 1.129 (0.81
Abbreviations: OR Odds ratio, CI confidence interval, OA osteoarthritis, MetS metabo
lipoprotein cholesterol.
Model 1: unadjusted. Model 2: adjusted for age, height exercise, alcohol intake, and
and 1.089 (1.069, 1.108) in female subjects, and no significance was found with othknee OA in this study could be that the knee OA sub-
jects of this study may have had milder osteoarthritis
than those of previous studies. Since the subjects with
knee OA in previous studies included patients who had
undergone total knee arthroplasty or high tibial osteot-
omy [3,8], the subjects might have had more severe knee
OA than those of the current study.
Knee OA is thought to be associated with multifactorial
causes [1]. There is a general consensus that knee OA is
strongly associated with obesity. It has been reported that
subjects with BMI >30 kg/m2 show a 4.2 − 6.8 times
higher incidence of knee OA than control subjects [31,32].
In the current study, we also found that WC in female
subjects was significantly related to knee OA. The reason
for this is uncertain, but the prevalence of knee OA is
known to be significantly higher in female subjects in
Asian populations, [23,27,33-35] which was confirmed
in this study as well. In addition to the mechanical ef-
fects of obesity or WC, knee OA is known to be closely
related to inflammation and excessive production of
proinflammatory cytokines, which are thought to play a
role in the pathophysiology and disease progression of
knee OA [12-15,36,37]. Serum concentrations of inflam-
matory markers, such as IL-6 and TNF-α have been
shown to be higher in patients who have knee or hip
OA [12-14], and are reported to be associated with in-
creased radiographic progression of knee OA [13,15,37].MetS
Model 2
ale Male Female
% CI) OR (95% CI) OR (95% CI)
4, 2.743) 1.356 (0.650, 2.828) 1.838 (1.311, 2.576)
0, 2.722) 0.710 (0.361, 1.397) 0.933 (0.653, 1.334)
0, 1.235) 1.458 (0.748, 2.839) 0.822 (0.591, 1.143)
7, 1.566) 0.997 (0.498, 1.999) 1.045 (0.742, 1.471)
6, 1.560) 1.020 (0.513, 2.027) 1.029 (0.724, 1.461)
lic syndrome, WC waist circumference, HTN hypertension, HDL - C high density
smoking. ORs (95% CI) in Model 2 was 1.094 (1.060, 1.130) in male subjects
er factors.
Table 4 Prevalence of knee OA according to the quartile of waist circumference
Q1 Q2 Q3 Q4
Male Female Male Female Male Fe e Male Female
WC (Mean ± SDcm) 75.1 ± 4.2 69.7 ± 3.3 83.0 ± 1.4 77.8 ± 1.7 87.8 ± 1.4 83. .7 95.3 ± 4.6 92.9 ± 5.2
Prevalence of Knee OA 15/254 (5.9%) 31/302 (10.3%) 6/255 (0.6%) 46/304 (15.1%) 7/256 (2.7%) 66/30 .7%) 13/255 (5.1%) 86/304 (25.0%)
Adjusted OR† 1.0 1.0 0.8 (0.314-2.198) 1.3 (0.879-2.170) 0.4 (0.149-1.214) 1.7 (1.0 .734) 0.9 (0.377-2.284) 2.3 (1.144-3.546)
Abbreviations: OA osteoarthritis, WC waist circumference, Q quartile, OR Odds ratio.
†ORs adjusted for age, sex, exercise, alcohol intake, and smoking. Adjusted ORs are presented with 95% Confidence Interval in parentheses.
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http://www.biomedcentral.com/1471-2458/13/603Diffusion of these cytokines from the synovial fluid into
the cartilage is thought to contribute to cartilage matrix
loss by stimulating chondrocyte catabolism and inhibiting
anabolism in OA [11]. Furthermore, Singh et al. [38]
reported that subjects with OA had a higher prevalence
of DM and HTN, and proposed that pathology of small
vessels in the subchondral bone could play a role in the
development of OA. However, we found no significant
correlations between the parameters of MetS, except for
WC in female subjects, and knee OA in the current
study. This may implicate that inflammatory pathways
might not be correlated with knee OA; moreover, Onat
et al. reported that there is discordance between insulin
resistance and MetS [39]. However, we still believe that
the relationship between MetS and knee OA deserves
further study, because problematic complications such
as deep vein thrombosis after procedures related to knee
OA are known to be associated with MetS [9].
Several limitations should be noted in this study. First,
the current study was a cross sectional study, which lim-
ited our ability to determine the causes and effects of MetS
on knee OA. However, KNHANES is a representative
sample of the general Korean population, and thus, our re-
sults could be generalized for the entire South Korean
population. Second, there was a relatively small number of
subjects with knee OA in this study, especially among
males. This could explain why the prevalence of MetS was
not significantly higher in subjects with knee OA than
those without knee OA. Finally, identification of knee OA
was derived mainly from a self-reporting manner, because
KHANES did not include radiologic evaluation or physical
examination for knee OA. We tried to exclude the subjects
who may have been biased during sample selection, but
we admit that our results could be different in knee OA
subjects diagnosed by radiologic and physical examina-
tions. Nevertheless, we showed that the prevalence of
knee OA was consistent with other population based
studies based on radiographs [40].
Conclusions
We found that WC was associated with knee OA in female
subjects, but neither MetS nor any parameters thereof were
shown to be associated with knee OA in the Korean sub-
jects of this study. Although we found no relationship
between a pre-inflammatory state of MetS and knee OA,
we believe further investigation of this relationship in vari-
ous aspects is warranted, as MetS may also be a risk factor
for complications in knee OA related procedures.
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